Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymosin α1 for Elderly Sepsis Patients After Discharge
ChiCTR2600121055Phase 2Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Mar 2026
- Modality
- Modified Peptides → Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in sepsis comparing Intervention Group (Thymosin α1) with Control Group (Normal saline placebo) (2 arms). Primary endpoint: Treatment Compliance. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
thymosin alpha 1
03
Conditions
sepsis
Beyond the preview
Go deeper on ChiCTR2600121055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600121055.